Download PDF
Thromb Haemost 2003; 90(06): 1218-1220
DOI: 10.1055/s-0037-1613428
Letters to the Editor
Schattauer GmbH

Fcγ RIIa-R131H polymorphism: Its impact on coronary heart disease in a German cohort

Andreas Gardemann
,
Anna Horstmann
,
Sentot Santoso
Further Information

Publication History

Received 27 June 2003

Accepted after revision 12 September 2003

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999; 340: 115-26.
    CrossrefPubMedGoogle Scholar
  • 2 Pfeiffer JR, Howes PS, Waters MA. et al. Levels of expression of Fcγ receptor IIA (CD32) are decreased on peripheral blood monocytes in patients with severe atherosclerosis. Atherosclerosis 2001; 155: 211-8.
    CrossrefPubMedGoogle Scholar
  • 3 Van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991; 49: 511-24.
    CrossrefPubMedGoogle Scholar
  • 4 Ratcliffe NR, Kennedy SM, Morganelli PM. Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions. Immunol Lett 2001; 77: 169-74.
    CrossrefPubMedGoogle Scholar
  • 5 Calverley DC, Brass E, Hacker MR. et al. Potential role of platelet Fc-γ RIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis 2002; 164: 261-7.
    CrossrefPubMedGoogle Scholar
  • 6 Clark MR, Clarkson SB, Ory PA. et al. Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J Immunol 1989; 143: 1731-8.
    PubMedGoogle Scholar
  • 7 Warmerdam PAM, van de Winkel JG, Gosselin EJ. et al. Molecular basis for a poly-morphism of human Fcg receptor II (CD32). J Exp Med 1990; 172: 19-26.
    CrossrefPubMedGoogle Scholar
  • 8 Stein MP, Edberg JC, Kimberly RP. et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 2000; 105: 369-76.
    CrossrefPubMedGoogle Scholar
  • 9 Ridker PM, Cushman M, Stampfer MJ. et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-8.
    CrossrefPubMedGoogle Scholar
  • 10 Rosenson RS, Koenig W. High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Curr Opin Cardiol 2002; 17: 325-31.
    CrossrefPubMedGoogle Scholar
  • 11 Gardemann A, Lohre J, Katz N. et al. The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 2002; 60: 167-75.
    PubMedGoogle Scholar
  • 12 Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606
    CrossrefPubMedGoogle Scholar
  • 13 Flesch BK, Bauer F, Neppert J. Rapid typing of the human Fc gamma receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion 1998; 38: 174-6.
    CrossrefPubMedGoogle Scholar